These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38617511)

  • 1. The activation of HAMP promotes colorectal cancer cell proliferation through zinc-mediated upregulation of SMAD4 expression.
    Pan F; Hu M; Ye T; Gan J; Ling M; Liu M
    Transl Cancer Res; 2024 Mar; 13(3):1493-1507. PubMed ID: 38617511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis.
    Wei FZ; Mei SW; Wang ZJ; Chen JN; Zhao FQ; Li J; Xiao TX; Zhao W; Ma YB; Yuan W; Liu Q
    Front Oncol; 2022; 12():884474. PubMed ID: 35992796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer.
    Liu C; Lu Z; Yan J; Xue D; He X; Huang W; Sun Q; Zhao W; Li F
    Front Oncol; 2023; 13():1234045. PubMed ID: 37564935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2.
    Yan Z; Zhou Y; Yang Y; Zeng C; Li P; Tian H; Tang X; Zhang G
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer.
    Liu J; Li Y; Xiao Q; Li Y; Peng Y; Gan Y; Shu G; Yi H; Yin G
    BMC Cancer; 2022 Oct; 22(1):1038. PubMed ID: 36195841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
    Guo X; Li Y; Chen X; Sun B; Guo X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic model based on tumor microenvironment and immune cell in colorectal cancer.
    Lin Y; Chen Y; Gan L; Li Z; Shen F
    Scand J Gastroenterol; 2024 Mar; 59(3):304-315. PubMed ID: 37978827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
    Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and
    Guo M; Li X; Li J; Li B
    Heliyon; 2023 Jun; 9(6):e17101. PubMed ID: 37389063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis.
    Wang L; Liu D; Liu S; Liao T; Jiao Y; Jiang X; Wang Y; Chen Y; Ma H; Cai H
    Transl Oncol; 2022 Jul; 21():101435. PubMed ID: 35483170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis.
    Zhang GJ; Li Y; Zhou H; Xiao HX; Zhou T
    Mol Med Rep; 2014 Jul; 10(1):283-91. PubMed ID: 24737193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the role of miR-137-3p/miR-296-5p/SERPINA3 signaling in colorectal cancer progression: integrative analysis of gene expression profiles and in vitro studies.
    Liu H; Wu X; Wang D; Li Q; Zhang X; Xu L
    BMC Med Genomics; 2023 Dec; 16(1):327. PubMed ID: 38087342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
    Luo Q; Zhou P; Chang S; Huang Z; Zeng X
    Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
    Wang Z; Du Y
    Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.